BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 15271402)

  • 1. Autologous hematopoietic cell transplantation for chronic myelogenous leukemia.
    Bhatia R; McGlave PB
    Hematol Oncol Clin North Am; 2004 Jun; 18(3):715-32, xi. PubMed ID: 15271402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous stem cell transplantation in chronic myeloid leukemia.
    Olavarria E
    Semin Hematol; 2007 Oct; 44(4):252-8. PubMed ID: 17961724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous stem cell transplantation for patients with chronic myeloid leukemia. The Argentine Group of Bone Marrow Transplantation (GATMO) experience.
    Koziner B; Dengra C; Lucero G; Klein G; Cánepa C; Milovic V; Milone G; Robinson A; Cerutti I; Saporito G; Kusminsky G; Milone J; Bordone J; Lastiri F;
    Cancer; 2002 Dec; 95(11):2339-45. PubMed ID: 12436440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eradication of the Philadelphia chromosome-positive clone and persistent restoration of normal polyclonal haemopoiesis in a chronic myelogenous leukemia patient after autologous transplant with peripheral blood Philadelphia-negative haemopoietic cells.
    Carella AM; Frassoni F; Podesta M; Saglio G
    Bone Marrow Transplant; 1994 May; 13(5):668-9. PubMed ID: 7914449
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic myelogenous leukemia: in search of the benign hematopoietic stem cell.
    McGlave P; Verfaillie C; Miller J
    Stem Cells; 1993 Oct; 11 Suppl 3():10-3. PubMed ID: 7905318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mobilisation of Ph-negative peripheral blood stem cells in CML with idarubicin and cytarabine.
    Chalmers EA; Franklin IM; Kelsey S; Clarke R; Sproul AM; Goldstone AH; Hepplestone A; Watson W; Sharp S; Tansey P
    Bone Marrow Transplant; 1994; 14 Suppl 3():S38-41. PubMed ID: 7697006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts.
    Yang H; Eaves C; de Lima M; Lee MS; Champlin RE; McMannis JD; Robinson SN; Niu T; Decker WK; Xing D; Ng J; Li S; Yao X; Eaves AC; Jones R; Andersson BS; Shpall EJ
    Bone Marrow Transplant; 2006 Mar; 37(6):575-82. PubMed ID: 16435011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era: a preliminary assessment.
    Simon W; Segel GB; Lichtman MA
    Blood Cells Mol Dis; 2006; 37(2):116-24; discussion 125-7. PubMed ID: 16904348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous transplant for chronic myelogenous leukemia using marrow treated ex vivo with mafosfamide.
    Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Cottafavi L; Dotti GP; Rizzoli V
    Bone Marrow Transplant; 1994 Sep; 14(3):425-32. PubMed ID: 7994267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autografting Ph-negative blood precursor cells in chronic myeloid leukaemia.
    Frassoni F; Giordano D; PodestĂ  M; Piaggio G; Benvenuto F; Pitto A; Figari O; Dejana A; Lerma E; Vassallo F; Sessarego M; Carella A
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S59-62. PubMed ID: 8769704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease.
    DeAngelo DJ; Hochberg EP; Alyea EP; Longtine J; Lee S; Galinsky I; Parekkedon B; Ritz J; Antin JH; Stone RM; Soiffer RJ
    Clin Cancer Res; 2004 Aug; 10(15):5065-71. PubMed ID: 15297408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous stem cell transplantation in chronic myeloid leukaemia using Philadelphia chromosome negative blood progenitors mobilised with hydroxyurea and G-CSF.
    Pratt G; Johnson RJ; Rawstron AC; Barnard DL; Morgan GJ; Smith GM
    Bone Marrow Transplant; 1998 Mar; 21(5):455-60. PubMed ID: 9535037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo purging with NK-92 prior to autografting for chronic myelogenous leukemia.
    Maki G; Tam YK; Berkahn L; Klingemann HG
    Bone Marrow Transplant; 2003 Jun; 31(12):1119-25. PubMed ID: 12796791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autografting in chronic myeloid leukemia.
    Carella AM; Beltrami G; Corsetti MT
    Semin Hematol; 2003 Jan; 40(1):72-8. PubMed ID: 12563613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autologous hemopoietic stem cell transplantation in treatment of chronic myelogenous leukemia].
    Sacha T; Hawrylecka D; Skotnicki AB
    Przegl Lek; 1999; 56 Suppl 1():62-6. PubMed ID: 10494185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autologous transplantation of Ph-negative peripheral blood stem cells for treatment of chronic myelogenous leukemia].
    Hatsuse M; Okano A; Okamoto A; Shimura K; Takahashi R; Hirai H; Ashihara E; Inaba T; Fujita N; Shimazaki C; Nakagawa M
    Rinsho Ketsueki; 2000 Aug; 41(8):671-5. PubMed ID: 11020996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular remission of CML after autotransplantation followed by adoptive transfer of costimulated autologous T cells.
    Rapoport AP; Levine BL; Badros A; Meisenberg B; Ruehle K; Nandi A; Rollins S; Natt S; Ratterree B; Westphal S; Mann D; June CH
    Bone Marrow Transplant; 2004 Jan; 33(1):53-60. PubMed ID: 14578928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early prediction of molecular remission by monitoring BCR-ABL transcript levels in patients achieving a complete cytogenetic response after imatinib therapy for posttransplantation chronic myelogenous leukemia relapse.
    Kim YJ; Kim DW; Lee S; Min CK; Goh HG; Kim SH; Lee JY; Kim YL; Kim HJ; Kim HJ; Lee JW; Kim TG; Min WS; Kim CC
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):718-25. PubMed ID: 15389438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Successful attainment of the third chronic phase by autologous peripheral blood stem cell transplantation and imatinib in a patient with chronic myeloid leukemia].
    Tabata S; Ohno T; Tomo K; Hishita T; Hada S; Mizumoto T; Furukawa H
    Rinsho Ketsueki; 2003 May; 44(5):313-7. PubMed ID: 12822405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collection of Ph-negative progenitor cells from Ph+ CML patients in complete cytogenetic remission after long-term interferon-alpha therapy.
    Russo D; Martinelli G; Montefusco V; Amabile M; Rosti G; Marin L
    Haematologica; 1999 Oct; 84(10):953-5. PubMed ID: 10509048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.